• COVID-19 Vaccine Protection Among Children Plummets Within Months: CDC Study

    COVID-19 Vaccine Protection Among Children Plummets Within Months: CDC Study Authored by Zachary Stieber via The Epoch Times, Children who received an original COVID-19 vaccine have little protection against hospitalization just months after vaccination, according to a new study from the U.S. Centers for Disease Control and Prevention (CDC). Children initially have 52 percent protection against hospitalization but that estimated effectiveness plummeted to 19 percent after four...

  • FDA approves new drug for urinary tract infections

    Uncomplicated urinary tract infections is a very common condition impacting women and the most frequent reason for antibiotic use, according to the FDA.

  • New targeted treatment approved for children with brain cancer

    The drugs improve children’s response rate to treatment and survival time without the disease getting worse.

  • With whooping cough cases on the rise, do you need a booster vaccine?

    As whooping cough cases are surging globally, some may wonder if it’s necessary to get a booster. Cases of the childhood respiratory disease also known as pertussis are surging internationally and in parts of the U.S., according to a recent report. Bordetella pertussis is a type of bacteria that causes a very contagious respiratory infection

  • WHO official advised Finland against COVID passports but government ignored her

    Dr. Hanna Nohynek testified that she told the Finnish government the 'vaccine passport' was not necessary. But despite Nohynek's role at the WHO and as chief physician at the Finnish Institute for Health and Welfare, the government ignored her.

  • CDC finds no link between COVID vaccines and cardiac deaths

    The U.S. Centers for Disease Control and Prevention found no link between COVIDovid vaccines and cardiac deaths among young people.

  • FDA approves bladder cancer treatment by Culver City company

    The Food and Drug Administration on Monday approved a new treatment for a type of bladder cancer. The treatment, which will be sold under the brand name Anktiva, is intended for some patients suffering from certain types of non-muscle invasive bladder cancer, according to an FDA statement announcing the approval. News of the FDA action was first reported by Reuters, which said, "The therapy works by activating types of disease fighting white blood cells called natural killer (NK) cells and...

  • HSE's Spring booster vaccination programme gets underway on Monday

    Dr Jessop said the HSE aims to complete this booster programme by the end of May.

  • COVID Not Linked to Increased Asthma Risk in Children: New Study

    A recent study disproves the notion of COVID-19's increased risk of asthma in children. There's no proof that a child's chance of developing asthma is increased by a COVID-19 infection, according to a recent study.

  • COVID-19 Vaccine Emails: Here’s What The CDC Hid Behind Redactions

    COVID-19 Vaccine Emails: Here’s What The CDC Hid Behind Redactions Authored by Zachary Stieber via The Epoch Times (emphasis ours), The U.S. Centers for Disease Control and Prevention (CDC) hid how a woman who suffered chest pain and other symptoms following COVID-19 vaccination received a shot because of a mandate at work, newly obtained documents show. The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Ga., on Aug. 25, 2023. (Madalina Vasiliu/The Epoch...

  • NIH Refuses To Release Details Of COVID-19 Vaccine Royalty Agreement

    NIH Refuses To Release Details Of COVID-19 Vaccine Royalty Agreement Authored by Zachary Stieber via The Epoch Times (emphasis ours), The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a COVID-19 vaccine that has earned it at least $400 million. Syringes of Moderna COVID-19 vaccines at a vaccination site in Los Angeles, on Feb. 16, 2021. (Apu Gomes/AFP via Getty Images) The NIH declined to provide any...

    • KIFI

    UN approves an updated cholera vaccine that could help fight a surge in cases

    By The Associated Press The World Health Organization has approved a new version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile. In a decision last week, WHO authorized a new vaccine by EuBiologics, the only maker of the oral cholera vaccine for